SMBA 1

• CAT Number: I011163
• CAS Number: 906440-37-7
• Molecular Formula: C20H13NO3
• Molecular Weight: 315.33
• Purity: ≥95%
• Synonyms: 2-[(2-Nitro-9H-fluorene-9-ylidene)methyl]phenol
• Target: Bcl-2 Family
• Solubility: Soluble to 100 mM in DMSO and to 10 mM in ethanol with gentle warming
• Storage: Store at -20C
• IUPAC Name: 2-[(Z)-(2-nitrofluoren-9-ylidene)methyl]phenol
• InChI: InChI=1S/C20H13NO3/c22-20-8-4-1-5-13(20)11-18-16-7-3-2-6-15(16)17-10-9-14(21(23)24)12-19(17)18/h1-12,22H/b18-11-
• InChIKey: PEYKRJBXACUOOB-WQRHYEAKSA-N
• SMILES: C1=CC=C(C(=C1)/C=C\2/C3=CC=CC=C3C4=C2C=C(C=C4)[N+](=O)[O-])O

SMBA-1 (Cat No.:I011163) is an experimental compound that selectively targets and modulates the β1-adrenergic receptor, a key receptor involved in cardiovascular regulation. By selectively enhancing or inhibiting β1-receptor activity, SMBA-1 has the potential to treat conditions such as heart failure, arrhythmias, and hypertension, where β1-adrenoceptor signaling plays a crucial role. It is designed to offer therapeutic benefits with fewer side effects compared to traditional β-blockers by targeting specific receptor subtypes. SMBA-1 is currently undergoing preclinical studies to assess its safety and efficacy for cardiovascular-related diseases.